The endocannabinoid system and Alzheimer's disease (Q34704881)

4 August 2017

The endocannabinoid system and Alzheimer's disease (English)

1 reference

4 August 2017

0 references

endocannabinoid system

0 references

author name string

Cristina Benito

1

1 reference

4 August 2017

Estefanía Núñez

2

1 reference

4 August 2017

María Ruth Pazos

3

1 reference

4 August 2017

Rosa María Tolón

4

1 reference

4 August 2017

Julián Romero

5

1 reference

4 August 2017

language of work or name

1 reference

1 August 2007

1 reference

4 August 2017

Molecular Neurobiology

1 reference

4 August 2017

36

1 reference

4 August 2017

75-81

1 reference

4 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s12035-007-8006-8

4 August 2017

0 references

cites work

Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration

1 reference

12 December 2020

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.

1 reference

12 December 2020

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

1 reference

12 December 2020

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

1 reference

12 December 2020

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

1 reference

12 December 2020

Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation

1 reference

12 December 2020

Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the C

1 reference

12 December 2020

Deciphering the molecular basis of memory failure in Alzheimer's disease

1 reference

12 December 2020

A molecular link between the active component of marijuana and Alzheimer's disease pathology

1 reference

12 December 2020

Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.

1 reference

12 December 2020

Alzheimer disease and neuroinflammation.

1 reference

12 December 2020

Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia.

1 reference

12 December 2020

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation

1 reference

12 December 2020

In-vivo measurement of activated microglia in dementia

1 reference

12 December 2020

1 reference

12 December 2020

Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells

1 reference

12 December 2020

Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.

1 reference

12 December 2020

Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease.

1 reference

12 December 2020

Current pharmacotherapy for Alzheimer's disease

1 reference

12 December 2020

Inflammation in neurodegenerative disease--a double-edged sword

1 reference

12 December 2020

Inflammation and Alzheimer's disease

1 reference

12 December 2020

Cannabinoid function in learning, memory and plasticity

1 reference

12 December 2020

Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement

1 reference

12 December 2020

Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.

1 reference

12 December 2020

The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease

1 reference

12 December 2020

The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells

1 reference

12 December 2020

Adverse reactions to delta-9-tetrahydrocannabinol given as an antiemetic in a multicenter study

1 reference

12 December 2020

Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease.

1 reference

12 December 2020

Functional neuroanatomy of the endocannabinoid system

1 reference

12 December 2020

Cannabinoid receptors in microglia of the central nervous system: immune functional relevance

1 reference

12 December 2020

Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains

1 reference

12 December 2020

Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model

1 reference

12 December 2020

New directions towards safer and effective vaccines for Alzheimer's disease.

1 reference

12 December 2020

Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains

1 reference

12 December 2020

Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade

1 reference

12 December 2020

Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels.

1 reference

12 December 2020

CB1 receptor selective activation inhibits beta-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons.

1 reference

12 December 2020

The pathogenesis of senile plaques

1 reference

12 December 2020

A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis.

1 reference

12 December 2020

Selective cannabinoid CB1 receptor-mediated inhibition of inducible nitric oxide synthase protein expression in C6 rat glioma cells.

1 reference

12 December 2020

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

12 December 2020

10.1007/S12035-007-8006-8

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference